Search for: "BENEFIT v. PFIZER, INC."
Results 181 - 200
of 201
Sorted by Relevance
|
Sort by Date
24 Nov 2015, 12:38 pm
High on the list of opinions that got it wrong are Kaiser Foundation Health Plan, Inc. v. [read post]
14 May 2007, 7:03 am
Pfizer, Inc., 2006 WL 2819046, at *7-8 (D.N.J. [read post]
7 Apr 2008, 2:56 pm
V. [read post]
22 Jul 2010, 5:25 am
Pfizer Inc., Civ. [read post]
1 Feb 2008, 12:00 am
: Industries Ltd v Dynamic Supply Pty Ltd: (IP Down Under)BrazilIFPI raids hundreds of internet cafes: 600 cops, one arrest: (Ars Technica)CanadaInterlocutory injunctions in trade mark cases: a difficult test to meet: CMAC Mortgages v Canadian Mortgage Expert Centre and CanadaHyundai Autov Cross Canada Auto Body Supply: (Canadian Trademark Blog), (coverage of Hyundia - IPblog), Privacy Coalition warns on copyright reform: (Michael Geist),Wikinomics on… [read post]
13 May 2012, 4:46 pm
Hospira, Inc. [read post]
10 Jan 2020, 9:32 am
Goodman Distr., Inc., 694 F. [read post]
12 Nov 2017, 11:00 pm
In the following guest post, attorneys from the Paul Weiss law firm review a recent Second Circuit decision on this issue, Waggoner v. [read post]
29 Aug 2008, 1:25 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC sets strict standards to establish inequitable conduct: Star Scientific v R J Reynolds Tobacco: (Hal Wegner), (Maryland Intellectual Property Law Blog), (Patent Prospector), (Patent Docs), (Patently-O), (more from Patently-O), (Philip Brooks), (Law360), (I/P Updates), Safe harbour ruling in Io v Veoh could help YouTube in Viacom… [read post]
5 Sep 2008, 11:01 pm
& Ors v Deisel Spa and Case C-302/08 Zino Davidoff SA v Bendesfinanzdirektion Sudost: (Class 46), EPO Boards of Appeal finds that when a fax is transmitted and an ‘OK’ is noted by the sender, this is evidence that the transmission was successful: (IPKat), Professor Hugenholtz slams European Commission for ignoring evidence on copyright extension: (Techdirt) Germany Federal Patent Court publishes guidelines on colour trade mark Signal Yellow:… [read post]
18 Jul 2008, 8:34 am
: (The IP ADR Blog), ACTA plans do not include iPod frisking: (Out-Law), Europe may put ACTA back on faster track: (Intellectual Property Watch), USTR posts ACTA submissions: (Michael Geist), (Vol 1 - IP Justice), (Vol 2 – IP Justice), (Vol 3 – IP Justice), (Vol 4 – IP Justice), G8 on IP: (IPKat), IP: A means to an access and benefit-sharing end? [read post]
28 Nov 2011, 4:02 am
Courts have precluded the use of class actions against drug makers in most cases (see, e.g., Valentino v. [read post]
9 May 2007, 1:34 pm
Stephenson v. [read post]
22 Mar 2008, 2:00 am
: (IP finance),ICANN proposes new anti-domain tasting solution: (Out-Law),Three strikes, three countries:France, Japan and Sweden: (Electronic Frontier Foundation)Global - PatentsTRIPS Council: Half of WTO membership backs biodiversity amendment: (Intellectual Property Watch),The costs and benefits of patents to innovators: (Patently-O), (response from Patent Prospector),Discussion of ‘Patent Failure: How Judges, Bureaucrats, and Lawyers Put Innovators at Risk’ by… [read post]
27 Dec 2011, 9:56 am
Janssen Pharmaceuticals, Inc., 951 N.E.2d 1238 (Ill. [read post]
15 Mar 2007, 2:12 am
Other pharmaceutical companies that have filed WIPO cases in the past include Pharmacia & Upjohn (in relation to Rogaine), American Home Products, McNeil Consumer Brands (Tylenol), Pfizer (Viagra), Merck, Sanofi-Aventis (Ambien), CVS Pharmacy, Lilly ICOS, Valeant, and Bayer. [read post]
17 Oct 2021, 2:17 pm
Kehm v. [read post]
8 Nov 2007, 1:04 pm
Pfizer, Inc., 2006 WL 2819046, at *9 (D.N.J. [read post]
13 Jul 2021, 10:58 am
In the United States (US), as for most developed countries,[6] trade policy and IP standards have consistently been linked, a pattern which can (at least partially) be traced back to extensive lobbying by senior management at US-based technology and pharmaceutical firms.[7] For example, since at least the 1980s, Pfizer Inc. has been involved in mobilizing other US firms and stakeholders to lobby US policymakers on the issue of international IP protection. [read post]
3 Jan 2023, 1:47 pm
The directors’ and officers’ liability environment is always changing, but 2022 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]
